Clinical Trials Directory

Trials / Completed

CompletedNCT05163236

Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening

Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening and Interval Cancer Risk : a Population Based Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,149 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
50 Years – 77 Years
Healthy volunteers
Not accepted

Summary

Fecal immunochemical test (FIT) was introduced in France late 2015, FIT has better diagnostic accuracy for colorectal cancers (CRCs) than previous screening tests. Our primary objective was to evaluate the sensitivity of FIT and the proportion of interval cancer.

Detailed description

Fecal immunochemical test (FIT) aims to detect pre-symptomatic lesions, i.e., early stage colorectal cancers (CRCs) or pre-cancerous lesions such as colonic adenomas in order to reduce CRC mortality. FIT was introduced in France late 2015, FIT has better diagnostic accuracy for CRCs than previous screening tests. Determining the incidence of post-test interval CRCs, diagnosed after a negative FIT and before the recommended date of the next test (2-year interval), allows assessment of the sensitivity of the test. The primary objective of this study was to evaluate the performance of FIT during the CRC screening campaign in the Finistère department (France) from January 1, 2016 to December 31, 2017. Its secondary objectives were the evaluation of diagnostic circumstances and their impact on treatment and survival, and risk factors for interval cancer (IC).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPositive fecal immunochemical test (FIT)We evaluated CRCs screening campaign from January 1, 2016 to December 31, 2017, and interval cancers within two years after a negative test, and five years for post-colonoscopy interval cancers.
DIAGNOSTIC_TESTNegative fecal immunochemical test (FIT)We evaluated CRCs screening campaign from January 1, 2016 to December 31, 2017, and interval cancers within two years after a negative test, and five years for post-colonoscopy interval cancers.
DIAGNOSTIC_TESTFecal immunochemical test (FIT) not performedWe evaluated CRCs screening campaign from January 1, 2016 to December 31, 2017, and interval cancers within two years after a negative test, and five years for post-colonoscopy interval cancers.

Timeline

Start date
2021-04-20
Primary completion
2021-10-11
Completion
2021-10-11
First posted
2021-12-20
Last updated
2021-12-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05163236. Inclusion in this directory is not an endorsement.